Influence of CCR5-Δ32 genotype in Spanish population with multiple sclerosis
- 10 March 2007
- journal article
- Published by Springer Nature in neurogenetics
- Vol. 8 (3) , 201-205
- https://doi.org/10.1007/s10048-007-0085-1
Abstract
A number of association studies have explored the relationship between the CCR5-Δ32 allele and the risk of developing multiple sclerosis (MS), with varying results. In light of the results of several studies that have analyzed the role of the allele in MS, it has been proposed that the allele is involved in the etiopathogeny of the disease. Our study revealed a statistically significant difference between the study group and the control group for the carriers of at least one deleted allele (P = 0.027). The allele was more frequent in the control group, which suggests a possible protective effect of this deletion against MS. When ethnic origin was taken into account in the same analysis, we saw that the bulk of the difference was attributable to the Basque group, although the trend was also visible in the control group. Consideration of ethnic origin is therefore essential for the analysis of our sample. CCR5-Δ32 allele distribution was higher in the Basque control population than in the Basque MS population, which suggests that it confers a protective effect against MS. Relevant values were a P value of 0.008 and an odds ratio of 0.168 (95% confidence interval, 0.038 to 0.737).Keywords
This publication has 36 references indexed in Scilit:
- UCP2 and mitochondrial haplogroups as a multiple sclerosis risk factorMultiple Sclerosis Journal, 2007
- A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHCNature Genetics, 2006
- Effect of high-dose methylprednisolone treatment on CCR5 expression on blood cells in MS exacerbationActa Neurologica Scandinavica, 2006
- CCR5Δ32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosisJournal of Neuroimmunology, 2005
- LGMD2A: genotype–phenotype correlations based on a large mutational survey on the calpain 3 geneBrain, 2005
- Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's DiseaseNeuron, 2004
- CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritisGenes & Immunity, 2000
- Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32Journal of Biological Chemistry, 1997
- A full genome search in multiple sclerosisNature Genetics, 1996
- Rating neurologic impairment in multiple sclerosisNeurology, 1983